Instead, we showed that the h-MDS subgroup had less frequent RUNX1, ASXL1, DNMT3A, EZH2, and TP53 mutations compared with the NH-MDS subgroup. The gene discussed is DNMT3A; the disease is myelodysplastic syndrome.